Adam Rogers
Direktor/Vorstandsmitglied bei NERVGEN PHARMA CORP.
Vermögen: 15 000 $ am 30.04.2024
Aktive Positionen von Adam Rogers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 14.07.2022 | - |
Präsident | 22.09.2022 | 10.04.2023 | |
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Vorstandsvorsitzender | 01.01.2017 | - |
Gründer | 01.01.2010 | - | |
Präsident | 01.01.2010 | 01.01.2017 | |
One Family, Inc. | Direktor/Vorstandsmitglied | 01.01.2007 | - |
Karriereverlauf von Adam Rogers
Ehemalige bekannte Positionen von Adam Rogers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Emory University School of Medicine | Corporate Officer/Principal | - | 02.01.1991 |
Ausbildung von Adam Rogers
Emory University School of Medicine | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 2 |
Operativ
President | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NERVGEN PHARMA CORP. | Health Technology |
Private Unternehmen | 2 |
---|---|
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Health Technology |
One Family, Inc. |
- Börse
- Insiders
- Adam Rogers
- Erfahrung